Raia Drogasil stock

RADL3 · B3 · BRL

Compare Raia Drogasil
R$13.72Change from previous close: 0.00%

Close · November 22, 2026

Price history

−39.68% over the period

1 year: from R$22.75 (November 24, 2025) to R$13.72 (November 22, 2026), −39.68%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 22, 2026R$13.72
October 30, 2026R$15.22
September 30, 2026R$18.37
August 31, 2026R$19.60
July 31, 2026R$18.48
June 30, 2026R$16.81
May 29, 2026R$18.69
April 30, 2026R$21.94
March 31, 2026R$23.53
February 27, 2026R$25.08
January 30, 2026R$24.50
December 30, 2025R$23.45
November 28, 2025R$23.54
November 24, 2025R$22.75

At a glance

  • The company

    Retail seller of medicines, perfumery, personal care, beauty products and cosmetics in Brazil

  • Latest results

    Quarter to September 30, 2026 · EPS R$0.24 (estimate R$0.25)

TickerLandia's take on Raia Drogasil

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk lowR$13.49
52-wk highR$27.42

−49.96% from the 52-week high

Analysts · 15 analysts

Average targetR$23.37+70.31% vs. price

Buy 13 · Hold 1 · Sell 1 · Buy

TickerLandia Fingerprint: Raia Drogasil

Compared with similar companies: very weak momentum.

Financials and price compared with 130 companies in related industries (retail), worldwide. Momentum and risk compared with 317 Latin American stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Raia Drogasil is cheaper than in the past and pricier than similar companies

On the latest fiscal year's earnings (2025), Raia Drogasil's P/E today is 17.5, below the median of its last 10 fiscal years (46.2; between 30.0 and 85.5 from 2016 to 2025). Raia Drogasil's P/E (trailing 12 months): 17.6, +22% against the median of a group of 10 similar companies (14.4).

P/E compared with its history

Compared with 10 similar companies

Raia Drogasil's metrics compared with similar companies
MetricRaia DrogasilPosition in the groupBand
P/E (trailing 12 months)17.6High
Forward P/E12.5Middle
Operating margin6.1%Middle
ROE19.7%High
Debt/equity1.17High

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Raia Drogasil. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

R$11.41B

Latest quarter · Q3 2026

Net income

R$408.25M

Latest quarter · Q3 2026

Quarterly net margin

3.6%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
R$23.99B
P/E
17.6
EPS
R$0.78
Volume
9.38M
Daily trading
€35.3M
Dividend yield
3.28%
Last ex-dividend on October 8, 2026

How Raia Drogasil is changing

All results
  • Revenue grew 17.1% a year on average over the last 5 years

  • Free cash flow equal to 84% of net income

  • Shares outstanding down 5.4% in 5 years

Returns

Raia Drogasil returns with dividends

R$1,000 invested in Raia Drogasil 5 years ago, on November 22, 2021, would be worth R$673 today with dividends reinvested: −32.72% in total, −7.62% per year. On price alone it would be R$624 (−37.64%).

PeriodRaia DrogasilIbovespaR$1,000 becomes
1 month−32.48%−18.87%R$675
6 months−24.57%−5.58%R$754
Year to date−41.49%+3.26%R$585
1 year−38.36%+7.15%R$616
3 years−47.96%+32.01%R$520
5 years−32.72%+62.92%R$673
10 years+23.96%+168.55%R$1,240

Over the last 6 months it has done better than 12% of the stocks in the Consumer sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. Ibovespa: with dividends. Calculate your investment

The chart in detail

Raia Drogasil: technical analysis

Raia Drogasil is in a downtrend: the price is below its 50- and 200-session moving averages, and the 200-session average is falling. The price is 53.5% below its all-time closing high (R$29.48, August 5, 2024).

Trend
Downward
RSI (14 sessions)
25
Below 30: a strong fall in a short time
vs 200-session average
−31.40%

Active signals

  • RSI below 30: the stock has fallen a lot in a short time.

    since November 5, 2026

Support and resistance

Price areas where Raia Drogasil has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. ResistanceR$17.62+28.41%4 touches, last on September 28, 2026
  2. ResistanceR$17.08+24.49%2 touches, last on August 18, 2026
  3. ResistanceR$16.28+18.62%2 touches, last on June 30, 2026
  4. Last priceR$13.72
  5. No support below: the price is near the lows of the year

Volatility and risk

Over the last year it has moved more than the Ibovespa.

Beta (1 year) vs Ibovespa
1.41
Volatility (60 sessions, annualised)
65.2%
Largest fall in the last year
−49.19%

In session, November 22, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Raia Drogasil: seasonality

Average monthly price change over 27 years

−0.1%Jan+4.8%Feb+2.8%Mar+2.0%Apr+1.7%May+18.0%Jun+3.6%Jul+0.5%Aug+1.6%Sep+1.0%Oct+13.7%Nov+1.9%Dec

Over the last 27 years, the strongest month for Raia Drogasil has been June: +18.01% on average, positive in 13 years out of 27. The weakest has been January: −0.13% on average, positive in 9 years out of 26. November, the current month, has been positive in 11 years out of 26 (+13.68% on average).

Show chart data
MonthAverageMedianPositive years
January−0.13%0.00%9 of 26
February+4.79%+0.86%14 of 27
March+2.81%+1.91%17 of 27
April+2.03%+0.74%14 of 27
May+1.74%0.00%11 of 27
June+18.01%0.00%13 of 27
July+3.62%+4.00%16 of 27
August+0.54%0.00%12 of 27
September+1.58%0.00%13 of 27
October+1.03%0.00%11 of 27
November+13.68%0.00%11 of 26
December+1.86%0.00%11 of 26

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Raia Drogasil and its competitors

Raia Drogasil's sales are made in Brazil, where the company runs a retail network selling pharmaceutical and health goods. Its range covers medicines of several kinds, perfumery, personal care and beauty lines, cosmetics, dermocosmetics and specialty drugs. Customers buy through physical stores, while telesales and call centers serve as additional routes to market. The company's activity is concentrated on the domestic market, and the group traces its origins back to 1905.

Headquarters
São Paulo, Brazil
Employees
77,428
Founded
1905
Chief executive
Renato Raduan
Raia Drogasil and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Raia DrogasilRADL3$4.04B6.1%17.6−24.57%
Alibaba Health Information Tech0241$5.4B5.3%20.1−33.12%
Redcare PharmacyRDC$1.47B0.3%—+36.52%
JD Health International6618$13.26B6.1%15.0−19.27%
InRetail PerúINRETC1$3.97B9.2%13.5+22.03%
CencosudCENCOSUD$4.56B4.9%23.8−22.16%

Same industry or related industries, similar size. Compare Raia Drogasil with its competitors · Full profile